Loading
institutionsInstitution
Prince of Wales Hospital / Chinese University of Hong Kong
The hospital where plasma EBV DNA screening for nasopharyngeal cancer and cell-free DNA cancer detection were invented by Dennis Lo's group.
Also called: PWHCUHK Faculty of MedicineSir Y.K. Pao Centre for Cancer威爾斯親王醫院
Overview
Prince of Wales Hospital in Sha Tin is the teaching hospital of the Chinese University of Hong Kong and houses the Sir Y.K. Pao Centre for Cancer and the Hong Kong Cancer Institute. Dennis Lo's laboratory at CUHK discovered plasma cell-free fetal DNA and then showed that plasma EBV DNA can screen asymptomatic men for early nasopharyngeal carcinoma, work that founded liquid biopsy and led to spin-outs including Cirina and GRAIL's early technology. Anthony Chan's group established concurrent chemoradiotherapy and EBV-DNA-guided treatment in NPC, and Joseph Sung's team advanced colorectal cancer screening across Asia. The hospital is a major site for gastrointestinal, hepatocellular and lung cancer trials in Hong Kong.
Location
Hong Kong, HK
Type
hospital · Chinese University of Hong Kong
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#277 · 24 points (0 Newsweek + 0 NCI + 24 from 12 linked objects) · ranking
- Plasma EBV DNA and liquid biopsy
- Nasopharyngeal carcinoma
- Colorectal cancer screening
- Hong Kong Cancer Institute
Anthony T. C. Chan
Li Shu Fan Medical Foundation Professor of Clinical Oncology; Director, Hong Kong Cancer Institute
Nasopharyngeal carcinomaHead and neck cancerEBV-related cancers
Leading nasopharyngeal carcinoma researcher who directs the Hong Kong Cancer Institute at CUHK.
Philip Wai Yan Chiu
Dean, Faculty of Medicine
Upper gastrointestinal surgeryEndoscopic surgeryGastric and oesophageal cancer
Upper GI surgeon and Dean of the CUHK Faculty of Medicine, the academic home of Prince of Wales Hospital.
Tony S. K. Mok
Chairman, Department of Clinical Oncology; Li Shu Fan Professor of Clinical Oncology
Lung cancerEGFR-targeted therapyPrecision oncology
Lung cancer pioneer whose IPASS trial established EGFR-targeted therapy as first-line treatment; chairs Clinical Oncology at CUHK.
Similar pages
- IdeaTrack clones in blood with methylation patterns instead of mutations
Shares GRAIL, DNA methylation profiling, Circulating tumour DNA (ctDNA), Liquid biopsy (ctDNA).
- Key paperClinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
Shares GRAIL, Multi-cancer early detection (MCED), DNA methylation profiling, Circulating tumour DNA (ctDNA).
- InstitutionQueen Mary Hospital / University of Hong Kong
Shares Plasma EBV DNA, Liquid biopsy (ctDNA), Hepatocellular carcinoma, Head and neck squamous cell carcinoma.
- CompanyHelio Genomics
Shares DNA methylation profiling, Liquid biopsy (ctDNA), Hepatocellular carcinoma, Colorectal cancer.
- IdeaPre-agreed update rules so an MCED test is not obsolete when its trial reads out
Shares GRAIL, Multi-cancer early detection (MCED), DNA methylation profiling.
- CompanyClearNote Health
Shares Multi-cancer early detection (MCED), DNA methylation profiling, Liquid biopsy (ctDNA).
- CompanyUniversal DX
Shares DNA methylation profiling, Liquid biopsy (ctDNA), Colorectal cancer.
- CompanyVolitionRx
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA), Non-small-cell lung cancer.